Pulmonx Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.3% | 25.8% | 25.9% | 26.3% | 26.3% | 26.0% | 27.5% | 27.9% | 25.3% | 22.4% | 22.1% | 22.0% | 22.9% | |
| 73.7% | 74.2% | 74.1% | 73.7% | 73.7% | 74.0% | 72.5% | 72.1% | 74.7% | 77.6% | 77.9% | 78.0% | 77.1% | |
| 23.9% | 20.2% | 22.3% | 27.0% | 18.4% | 16.8% | 21.1% | 22.2% | 22.5% | 20.3% | 23.8% | 22.1% | 22.1% | |
| 135.8% | 101.3% | 129.4% | 121.8% | 124.6% | 80.4% | 116.0% | 111.9% | 119.1% | 101.2% | 117.1% | 95.6% | 107.9% | |
| 159.6% | 146.4% | 151.2% | 148.8% | 143.0% | 130.5% | 137.1% | 134.2% | 141.6% | 121.4% | 140.9% | 117.8% | 130.0% | |
| -85.9% | -72.2% | -77.1% | -75.2% | -69.3% | -56.5% | -64.6% | -62.0% | -66.9% | -43.8% | -62.9% | -39.8% | -53.0% | |
| 5.1% | 4.7% | 4.7% | 4.3% | 4.4% | 3.5% | 3.5% | 3.3% | 3.7% | 3.4% | 4.7% | 5.4% | 4.3% | |
| -84.0% | -70.8% | -71.9% | -73.3% | -68.4% | -55.3% | -63.5% | -62.9% | -64.3% | -45.3% | -65.6% | -43.7% | -54.3% | |
| 0.3% | 1.3% | 1.0% | 0.4% | 0.9% | 0.2% | 0.6% | 0.7% | 0.6% | 0.8% | 0.7% | 0.6% | 0.7% | |
| -84.3% | -72.0% | -72.9% | -73.7% | -69.4% | -55.4% | -64.1% | -63.6% | -64.9% | -46.1% | -66.3% | -44.3% | -55.0% | |
| -76.6% | -64.1% | -64.5% | -67.1% | -62.2% | -50.5% | -64.6% | -58.3% | -59.4% | -40.9% | -59.8% | -38.4% | -49.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.